Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$59.09 USD
+0.17 (0.29%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $59.95 +0.86 (1.46%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: AMC |
9/2024 | $-0.91 | 0.00% |
Earnings Summary
For their last quarter, Crinetics Pharmaceuticals (CRNX) reported earnings of -$0.94 per share, missing the Zacks Consensus Estimate of -$0.86 per share. This reflects a negative earnings surprise of 9.30%. Look out for CRNX's next earnings release on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.91 per share, reflecting a year-over-year increase of 9.9%.
Earnings History
Price & Consensus
Zacks News for CRNX
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services